MEDI0382, a GLP-1 and glucagon receptor dual agonist, in obese or overweight patients with type 2 diabetes: a randomised, controlled, double-blind, ascending dose and phase 2a study.
MEDI0382, a GLP-1 and glucagon receptor dual agonist in obese or overweight patients with type 2 diabetes: a randomised, controlled, double-blind, ascending dose and Phase 2a study